
|Videos|January 26, 2015
The Changing Landscape of Limited Distribution Specialty Drugs
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developing trends in the limited distribution of specialty medications.
Advertisement
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developing trends in the limited distribution of specialty medications.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral GLP-1 Orforglipron Is Approved for Obesity
2
Common Asthma Drug May Supercharge Cancer Immunotherapy, Study Finds
3
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
4
Why Drug Information Infrastructure—Not Model Size—Will Define the Future of Health Care AI
5
































































































































